Dengue vaccine, Dengvaxia: FDA grants priority review
by Press Release from Outbreak News Today on (#41Z52)
The United States Food and Drug Administration (FDA) has accepted a Biologics License Application for Sanofi Pasteur's dengue vaccine. The dengue vaccine candidate has been granted priority review by the FDA as it would represent the first and only medical prevention tool against dengue, including severe dengue, which is considered an unmet medical need. The ["]
The post Dengue vaccine, Dengvaxia: FDA grants priority review appeared first on Outbreak News Today.